Stay updated on Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page.

Latest updates to the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page
- Check5 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check12 days agoChange DetectedThe footer's site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe history now includes a new Revision: v3.7.0 and removes Revision: v3.6.6, updating the page's revision trail. This reflects an update to the page's versioning rather than substantive content changes to the study.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.6.6 appears on the page, replacing the previous v3.6.5. This indicates an updated build of the page’s interface and underlying systems.SummaryDifference0.0%

- Check75 days agoChange DetectedRecord history now lists a newer page revision (v3.6.5) replacing v3.6.4, indicating a minor version update to the page. It does not alter the study data or core content presented on the record.SummaryDifference0.0%

- Check89 days agoChange DetectedThe history now includes a new site revision: Revision: v3.6.4, replacing the prior Revision: v3.6.3. This reflects a maintenance/update to the page rendering and does not alter any study content.SummaryDifference0.0%

Stay in the know with updates to Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page.